Year : 2019 | Volume
: 11 | Issue : 2 | Page : 53-
State of the globe: Antimicrobial resistance: Are we ready?
Sunil Kumar Raina
Department of Community Medicine, Dr. RPGMC, Tanda, Kangra, Himachal Pradesh, India
Dr. Sunil Kumar Raina
Department of Community Medicine, Dr. RPGMC, Tanda, Kangra, Himachal Pradesh
|How to cite this article:|
Raina SK. State of the globe: Antimicrobial resistance: Are we ready?.J Global Infect Dis 2019;11:53-53
|How to cite this URL:|
Raina SK. State of the globe: Antimicrobial resistance: Are we ready?. J Global Infect Dis [serial online] 2019 [cited 2020 Jan 18 ];11:53-53
Available from: http://www.jgid.org/text.asp?2019/11/2/53/259151
Our understanding about antimicrobial resistance (AMR) has largely been restricted by the narrative focusing on “drugs and bugs,” even though this specific narrative does not work in line with the expected national narrative in this regard. The expected national narrative assumes significance in view of the fact that countries (including India) have committed to developing a national action plan on AMR and WHO and other partners are working to support national health authorities to develop and implement them. As Shri Jagat Prakash Nadda, Minister for Health and Family Welfare, Government of India, puts it, “We are ready with a blueprint that meets global expectations. The challenge now is in its efficient implementation through a coordinated approach at all levels of use of antibiotics,” but are we ready?
AMR is a cross-cutting issue, and the limited availability of existing primary sources of data makes the situation more difficult. Add to it the presence of multiple stakeholders from health care professionals to veterinarians to agriculturists to environmentalist, the challenge of tackling AMR becomes all the more difficult. However, the commitment of the policymakers appears to be a silver lining. The commitment is a way of beginning to understand and acknowledge how men and women, young and old and different groups in society, may be at risk of or impacted by AMR and the efforts to address it.
At present, it appears that our readiness to tackle AMR will stand challenged unless we understand the ground rules. AMR is about policies and the public. Although the impact of AMR may vary between individual; some groups in society may face greater or different risks of exposure to AMR, the answer to tackling this huge problem lies in efficient in planning. The challenges in accessing, using, and benefiting from the information, services, and solutions to tackle AMR have to be met with approaches driven apart from others by the healthcare professionals and policy advisors. The working together of all stakeholders in tackling AMR will help us understand how to design AMR strategies, programs, and activities in a way that will ensure their full success.
AMR is beyond drugs and bugs to people and realizing this Organized Medicine Academic Guild came up with a status paper highlighting the action points to fight it (AMR) in India. The status paper is expected to help further the national narrative on AMR and thereby help policymakers tackle it as also serve as guidance to countries embarking on tackling AMR.
The idea is that unless we start planning as to how AMR and interventions therein affect people – in their day-to-day lives at home, at work, and in their communities – we inadvertently end up designing programs that fail to address what really matters, thereby losing effectiveness and impact. The status paper through action points avoids falling prey to ignoring issues and thereby contributing to gaps and inequities in society related to AMR. We expect that the guidance will evolve as it is applied and contributes to improved knowledge about how to design AMR strategies, programs, and activities in a way that will ensure their full success by better considering gender and equity issues.
|1||Raina SK, Galwankar S, Dhariwal AC, Bhatt R, Kumar R, Gilada I, et al. Fighting antimicrobial resistance: Status paper with action points by Organized Medicine Academic Guild. J Global Infect Dis 2019;11:54-8.|